Leukotriene inhibitors for treatment of asthma

Leukotriene inhibitors, which are given orally, can reduce the severity of asthma in some patients. There are several such products on the market, including Accolate, Zeileutin, and Singulaire. They can be very effective agents in some patients and should be given a serious trial in patients with chronic symptoms. They can also be considered first-line drugs.